Journal article Published 2021

Nociceptin/orphanin FQ opioid receptor (NOP) selective ligand MCOPPB links anxiolytic and senolytic effects

M. Raffaele, Kristina Kovacovicova, T. Biagini, O. Lo Re, J. Frohlich, S. Giallongo, J.D. Nhan, A.G. Giannone, D. Cabibi, M. Ivanov, A.B. Tonchev, Martin Mistrík, Mathew Lacey, Petr Džubák, Soňa Gurská,

Show all 21 authors

Marián Hajdúch, Jiří Bártek, T. Mazza, V. Micale, S. Curran, M. Vinciguerra

Geroscience 44(1), 463-483 (2021)

View on PubMed Cite

2021 Year
34820764 PMID

Cite this publication

RAFFAELE, M., K. KOVACOVICOVA, T. BIAGINI, O. LO RE, J. FROHLICH, S. GIALLONGO, J. NHAN, A. GIANNONE, D. CABIBI, M. IVANOV, A. TONCHEV, M. MISTRÍK, M. LACEY, P. DŽUBÁK, S. GURSKÁ, M. HAJDÚCH, J. BÁRTEK, T. MAZZA, V. MICALE, S. CURRAN, M. VINCIGUERRA: Nociceptin/orphanin FQ opioid receptor (NOP) selective ligand MCOPPB links anxiolytic and senolytic effects. Geroscience. 2021, 44(1), 463-483, ISSN: 2509-2715, PMID: 34820764.

Nociceptin/orphanin FQ opioid receptor (NOP) selective ligand MCOPPB links anxiolytic and senolytic effects

Cite this publication

Details

Authors from EATRIS